1.The Clinical study of Acute Poisoning in Children.
Ji Ho SONG ; Sang Young CHUNG ; Byoung Soo CHO ; Yong Mook CHOI ; Chang Il AHN
Journal of the Korean Pediatric Society 1989;32(10):1331-1336
No abstract available.
Child*
;
Humans
;
Poisoning*
2.Effects of Abdominal Visceral Fat Change on Regression of Erosive Esophagitis.
Gut and Liver 2019;13(1):1-2
No abstract available.
Esophagitis*
;
Intra-Abdominal Fat*
3.Correction: Antimicrobial Resistance of Helicobacter pylori Isolates in Korea
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019;19(1):77-77
The correction is being published to correct the grant number in above article.
4.Antimicrobial Resistance of Helicobacter pylori Isolates in Korea.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018;18(2):82-88
Antimicrobial resistance is a growing problem in the eradication of Helicobacter pylori. A combination therapy with proton pump inhibitor, clarithromycin, and amoxicillin is recommended as the first-line treatment regimen in Korea. However, the eradication rate with a standard triple therapy has been unsatisfactory in the last decade, and one of the main reasons for treatment failure is the increasing prevalence of strains resistant to antimicrobials. Therefore, comprehensive and detailed information on antimicrobial resistance is mandatory to optimize the strategy of eradication treatment. The antimicrobial resistance of H. pylori is reported to vary according to study population, geographical region, and test methods. In this review, the prevalence of antimicrobial resistance of H. pylori isolates in Korea is summarized on the basis of recent studies.
Amoxicillin
;
Clarithromycin
;
Drug Resistance, Microbial
;
Helicobacter pylori*
;
Helicobacter*
;
Korea*
;
Prevalence
;
Proton Pumps
;
Treatment Failure
5.Effects of Antiplatelet Agents on Bleeding after Endoscopic Resection of Gastric Tumor.
Gut and Liver 2018;12(4):369-370
No abstract available.
Hemorrhage*
;
Platelet Aggregation Inhibitors*
6.Effectiveness of Helicobacter pylori Eradication before Endoscopic Resection
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019;19(4):215-219
Helicobacter pylori (H. pylori) infection can cause gastric dysplasia and cancer via chronic inflammatory changes in the gastric mucosa that may lead to gastric atrophy and intestinal metaplasia. Many epidemiologic studies have demonstrated the prophylactic effects of H. pylori eradication on gastric cancer, and H. pylori eradication after endoscopic resection of early gastric cancer may prevent the occurrence of metachronous gastric cancer or dysplasia. Despite insufficient data on the effect of H. pylori eradication on gastric dysplasia and cancer before endoscopic resection, some studies have shown that H. pylori eradication can induce the regression or slow the progression of some gastric dysplasia. Therefore, eradication therapy before endoscopic resection may be effective in selected cases of low-grade dysplasia. However, endoscopic resection should be considered as the first-line treatment in high-grade dysplasia or early gastric cancer owing to the potential morphologic changes to some dysplasia or cancer that can be incurred by the eradication process, which may make it difficult to perform a subsequent endoscopic procedure.
Atrophy
;
Epidemiologic Studies
;
Gastric Mucosa
;
Helicobacter pylori
;
Helicobacter
;
Metaplasia
;
Stomach Neoplasms
7.A Rare Case of Bilateral Frontal Linear Scleroderma (En Coup de Sabre)
Joo Ran HONG ; Ji Su LEE ; Yang Won LEE ; Yong Beom CHOE ; Kyu Joong AHN
Korean Journal of Dermatology 2019;57(6):346-347
No abstract available.
Scleroderma, Localized
8.Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease
Gut and Liver 2019;13(6):585-586
No abstract available.
Helicobacter pylori
;
Helicobacter
;
Humans
;
Prevalence
;
Renal Insufficiency, Chronic